Whereas, some IFN-associated adverse events, including general fatigue, hair loss, and IFN-associated autoimmune diseases, as well as other maternal complications including pre-eclampsia, gestational diabetes, were not sufficiently evaluated in the current analysis. This evidence concerns the gene IFNA1 and autoimmune disease.